| Particulars | Mar2024 | Mar2023 | Mar2022 | Mar2021 |
|---|---|---|---|---|
| Revenue From Operations | 4,167.43 | 3,616.53 | 4,400.71 | 3,462.88 |
| Sale of Products | 3,662.55 | 3,264.35 | 3,969.99 | 3,131.45 |
| Sale of Services | 481.89 | 319.44 | 414.16 | 292.19 |
| Income from Investment and Financial Services | 0.00 | 0.00 | 0.00 | 0.00 |
| Particulars | Mar2024 | Mar2023 | Mar2022 | Mar2021 |
|---|---|---|---|---|
| Fixed Assets | 3,946.75 | 1,570.55 | 1,512.19 | 954.23 |
| Property, Plant and Equipments | 3,541.31 | 1,558.50 | 1,499.09 | 953.49 |
| Right-of-Use Assets | 50.96 | 0.39 | 0.57 | 0.75 |
| Intangible Assets | 354.48 | 11.66 | 2.54 | 0.00 |
| Market Cap (Rs in Crs) | 22,954.69 | |
|---|---|---|
| P/E | 20.47 | |
| Book Value (Rs) | 556.81 | |
| Div (%) | 2000 | |
| Market Lot | 1 | |
| EPS (TTM) | 68.05 | |
|---|---|---|
| Price/Book | 2.50 | |
| Div Yield.(%) | 1.44 | |
| Face value (RS) | 1 | |
| Deliverables (%) | 34.47 | |
| Company Name | Market Cap (₹) | LTP (₹) | Prev. Close (₹) | Chg(%) |
52 Week H/L(₹)
|
|---|---|---|---|---|---|
| Sun Pharmaceuti... | 3,96,394.13 | 1,652.10 | 1,688.75 | -2.17 | 1,960.20 - 1,376.75 |
| Divis Laborator... | 1,42,920.32 | 5,383.70 | 5,389.50 | -0.11 | 6,448.75 - 3,640.10 |
| Cipla Ltd | 1,14,382.81 | 1,416.30 | 1,433.45 | -1.20 | 1,702.00 - 1,310.05 |
| Torrent Pharmac... | 1,05,811.91 | 3,126.55 | 3,244.50 | -3.64 | 3,589.95 - 2,508.65 |
| Mankind Pharma ... | 95,480.99 | 2,314.25 | 2,343.55 | -1.25 | 3,050.00 - 1,910.10 |
Total Foreign
Total Institutions
Total Govt Holding
Total Non Promoter Corporate Holding
Total Promoters
Total Public & others
| Category | No. of Shares | Percentage |
|---|---|---|
| Total Foreign | 86,63,851 | 5.26 |
| Total Institutions | 5,73,27,449 | 34.80 |
| Total Govt Holding | 100 | 0.00 |
| Total Non Promoter Corporate Holding | 77,61,043 | 4.71 |
| Total Promoters | 8,53,93,934 | 51.83 |
| Total Public & others | 5605346 | 3.40 |
| Total | 16,47,51,723 | 100 |
